Your response is your advantage: Rebuild for pharma’s new era

Your response is your advantage: Rebuild for pharma’s new era

Pharma is facing multiple disruptions at once. Markets are fragmenting, AI is advancing, and care is becoming continuous rather than episodic.

Seeing the shifts won’t separate the winners - responding to them will.

Pulling ahead means redesigning strategy, operating models, and technology as one, and building change into how organizations operate. The leaders of pharma’s new era won’t be those who see the shifts first, but the ones who fully integrate the required changes in a way that lasts.

The next five years will not look like the past 50. Multiple forces are reshaping pharma at once, and companies that do not build the capacity to respond across all of them risk being left behind.

Build change that lasts

%

of healthcare and life sciences transformation programs fully achieve their targets.

Multiple forces reshaping pharma

Multiple forces reshaping pharma

1. Multipolar markets

Global pharma is becoming multipolar. A single global model may now destroy value.

Managing the Transition to a Multipolar Pharma Market

Read the insight

2. Clinical development

Clinical development is being reimagined to get the right medicine to patients in a fraction of the time.

Why This Is Clinical Development’s Defining Moment

Read the insight

3. AI at the point of care

Your next commercial channel isn’t another physician. It’s AI.

Coming soon

4. Individualized care

Precision medicine was step one. Individualized care is continuous.

The Doctor Is Always On: Dynamic Medicine Is the Next Frontier for Pharma

Read the insight

5. Change capability

Pharma has never had to be good at change. The window to build that muscle is narrowing fast.

Why Pharma Transformations Stall—and How to Fix Them

Read the insight

Your pharma experts